Saturday 17 October 2026
Export EMN’s income statement to Excel — free account
Eastman Chemical Company
EMN Basic Materials Specialty Chemicals
Eastman Chemical Company’s revenue for fiscal 2025 (year ended December 2025) was $8.8 billion, down 6.71% from fiscal 2024. In the quarter to June 2026, revenue grew 9.88%, EPS grew 31.2%, free cash flow grew 49.4% and total debt fell 6.90%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.
62.33
1.54
−2.41%
Follow EMN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
10.40 | 15.42 | 21.87 | 17.31 |
P/S ratio |
0.80 | 0.84 | 1.01 | 0.86 | |
P/FCF ratio |
18.26 | 17.27 | 17.50 | 14.20 | |
P/Operating CF |
17.94 | 14.58 | (63.62) | 34.18 | |
P/B ratio |
1.23 | 1.21 | 1.43 | 1.24 | |
Price to Tangible BV |
6.16 | 5.22 | 5.90 | 4.82 | |
EV/Sales |
1.28 | 1.25 | 1.45 | 1.29 | |
EV/EBITDA |
7.38 | 8.50 | 10.59 | 8.96 | |
EV/Operating CF |
11.42 | 11.30 | 12.50 | 11.52 | |
EV/FCF |
29.14 | 25.84 | 25.10 | 21.18 | |
Quick Ratio |
0.82 | 0.59 | 0.68 | 0.72 | |
Current Ratio |
1.76 | 1.37 | 1.47 | 1.50 | |
Net Debt/EBITDA |
13.43 | 18.93 | 11.87 | 8.49 | |
Debt/Assets |
31.94% | 28.27% | 29.23% | 28.86% | |
Debt/Equity |
0.82 | 0.70 | 0.73 | 0.72 | |
Asset Turnover |
0.60 | 0.58 | 0.57 | 0.58 | |
Operating CF/Net income |
8.55 | 4.78 | (1.28) | 1.22 | |
Capex/Depreciation |
(1.06) | (0.85) | (0.79) | (0.76) | |
Interest Coverage |
3.54 | 1.17 | 3.62 | 5.65 | |
Research and Development Expense of Revenue |
2.86% | 2.94% | 2.76% | 2.59% | |
Selling, General and Administrative Expense of Revenue |
7.27% | 8.06% | 8.18% | 7.36% | |
Intangible Assets out of Total Assets |
0.31 | 0.31 | 0.30 | 0.30 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.74) | (0.71) | (0.58) | (0.65) | |
Graham Number |
83.45 | 70.02 | 64.69 | 68.59 | |
Earnings Yield |
9.61% | 6.49% | 4.57% | 5.78% | |
Free Cash Flow Yield |
5.48% | 5.79% | 5.71% | 7.04% | |
Revenue per Share |
19.25 | 17.20 | 19.06 | 21.99 | |
Operating CF per Share |
3.51 | 4.38 | (1.20) | 1.96 | |
Capex per Share |
(1.20) | (0.98) | (0.90) | (0.87) | |
Free Cash Flow per Share |
2.32 | 3.40 | (2.10) | 1.08 | |
Cash per Share |
4.27 | 4.93 | 5.82 | 6.05 | |
Shareholders Equity per Share |
51.08 | 52.63 | 53.29 | 54.02 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
51.08 | 52.63 | 53.29 | 54.02 | |
Free Cash Flow |
265.00 | 390.00 | (240.00) | 124.00 | |
Working Capital |
1,631.00 | 993.00 | 1,288.00 | 1,415.00 | |
Capital Expenditures |
(137.00) | (112.00) | (103.00) | (100.00) | |
Net Current Asset Value |
(5,349.00) | (5,177.00) | (5,080.00) | (4,994.00) | |
EV/EBIT |
10.98 | 14.12 | 18.88 | 15.20 | |
Capex to Sales |
0.06 | 0.06 | 0.05 | 0.04 | |
Price to Operating Income |
6.88 | 9.43 | 13.17 | 10.19 | |
| Other line items | |||||
Average Receivables |
1,303.00 | 1,085.50 | 1,238.00 | 1,352.50 | |
Average Payables |
2,004.00 | 2,162.00 | 1,991.00 | 2,059.00 | |
Average Inventory |
1,920.50 | 1,984.00 | 2,097.00 | 2,126.00 | |
Average Assets |
15,019.50 | 15,036.00 | 15,096.50 | 15,321.50 | |
Average Common Equity |
5,785.50 | 5,944.50 | 6,015.00 | 6,040.50 |
Columns are period end dates